Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Pantalone

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Diabetes Research and Clinical Practice|August 7, 2024
The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitisLaura D Lomeli, Alimitha M Kodali, Yumiko Tsushima, et al.
Obesity Research & Clinical Practice|March 3, 2025
Weight gain following an employer-based randomized trial evaluating the treatment of obesity with and without anti-obesity medicationNoura Nachawi, Marcio L Griebeler, Huijun Xiao, et al.
Journal of Diabetes|May 2, 2015
Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland ClinicSubramanian Kannan, Kevin M Pantalone, Simone Matsuda, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2014
The clinical utility of free thyroxine in oral levothyroxine absorption testingGrace E Ching Sun, Kevin M Pantalone, Charles Faiman, et al.
Journal of CME|October 17, 2025
An Integrated Interprofessional Continuing Medical Education and Quality Improvement Initiative to Address Cardiovascular and Renal Risk in Patients with Type 2 Diabetes in Community-Based Primary Care PracticesPatrice Lazure, Kevin M Pantalone, Bethany Frampton, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|August 16, 2023
Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World StudyKevin M Pantalone, Caroline Heller, Rosemarie Lajara, et al.
Diabetes, Obesity & Metabolism|January 12, 2023
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world studyRosemarie Lajara, Caroline Heller, Kevin M Pantalone, et al.
Diabetes Research and Clinical Practice|May 22, 2024
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparisonBeatrice Osumili, Ludi Fan, Jim S Paik, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETESByron J Hoogwerf, Kevin M Pantalone, Marina Basina, et al.
Human Genomics|June 22, 2024
Polygenic subtype identified in ACCORD trial displays a favorable type 2 diabetes phenotype in the UKBiobank populationCourtney Hershberger, Arshiya Mariam, Kevin M Pantalone, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Diabetes Research and Clinical Practice|August 7, 2024
The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitisLaura D Lomeli, Alimitha M Kodali, Yumiko Tsushima, et al.
Obesity Research & Clinical Practice|March 3, 2025
Weight gain following an employer-based randomized trial evaluating the treatment of obesity with and without anti-obesity medicationNoura Nachawi, Marcio L Griebeler, Huijun Xiao, et al.
Journal of Diabetes|May 2, 2015
Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland ClinicSubramanian Kannan, Kevin M Pantalone, Simone Matsuda, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2014
The clinical utility of free thyroxine in oral levothyroxine absorption testingGrace E Ching Sun, Kevin M Pantalone, Charles Faiman, et al.
Journal of CME|October 17, 2025
An Integrated Interprofessional Continuing Medical Education and Quality Improvement Initiative to Address Cardiovascular and Renal Risk in Patients with Type 2 Diabetes in Community-Based Primary Care PracticesPatrice Lazure, Kevin M Pantalone, Bethany Frampton, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|August 16, 2023
Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World StudyKevin M Pantalone, Caroline Heller, Rosemarie Lajara, et al.
Diabetes, Obesity & Metabolism|January 12, 2023
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world studyRosemarie Lajara, Caroline Heller, Kevin M Pantalone, et al.
Diabetes Research and Clinical Practice|May 22, 2024
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparisonBeatrice Osumili, Ludi Fan, Jim S Paik, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETESByron J Hoogwerf, Kevin M Pantalone, Marina Basina, et al.
Human Genomics|June 22, 2024
Polygenic subtype identified in ACCORD trial displays a favorable type 2 diabetes phenotype in the UKBiobank populationCourtney Hershberger, Arshiya Mariam, Kevin M Pantalone, et al.
Pageof 11